Compounds of arsenic, nickel, calcium, chromium and beryllium are considered human carcinogens. Other metal compounds, while not proven human carcinogens, can cause tumors in experimental animals. The genetic effects of metal compounds are poorly understood. Bacterial short-term bioassays have been poor at predicting the carcinogenicity of metal compounds. In the previous funding period, it was found that genotoxic effects of metal compounds could be demonstrated in bacterial systems provided one used a narrow dose range of the compounds in a sub-toxic range, long-term exposure to growing cells, and a genetic endpoint of broad specificity. Using a newly developed microtitre system which simultaneously screens for toxicity, Lambda prophage induction, and mutagenicity, genotoxic effects were detected for compounds of chromium, nickel, lead, manganese, molybdenum and tungston. This system also allows detection of organic carcinogens at extremely low concentrations, including some which are negative in standard Ames strains. Compounds of copper, arsenite, manganese and molybdenum were detected in a comutagenesis assay. The present proposal has two parts. First, the microtitre system will be improved by incorporating a forward mutation assay capable of detecting base-pair substitutions, frameshifts and deletions. If feasible, an enzymatic assay for prophage induction (an indication of DNA damage) will replace the Lambda plaque assay. Second, the studies will be extended to eukaryotic cells, using the Chinese hamster V79 line. Gene mutations at the GHPRT locus, chromosome aberrations, sister chromatid exchanges and comutagenesis will be the genetic endpoints. The emphasis will be on a comparison between insoluble metal compounds (of particle size les than 5 Mum) and soluble compounds of the same metals. Insoluble particles cannot be assayed in bacterial systems. The use of eukaryotic cells will allow the study of compounds which do not enter bacteria, as well as providing a prokaryotic/eukaryotic comparison of the genetic toxicity of metal compounds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA029258-05
Application #
3168602
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1980-12-01
Project End
1987-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Klein, C B; Su, L; Rossman, T G et al. (1994) Transgenic gpt+ V79 cell lines differ in their mutagenic response to clastogens. Mutat Res 304:217-28
Wang, Z; Hou, G; Rossman, T G (1994) Induction of arsenite tolerance and thermotolerance by arsenite occur by different mechanisms. Environ Health Perspect 102 Suppl 3:97-100
Wang, Z; Rossman, T G (1994) Large-scale supercoiled plasmid preparation by acidic phenol extraction. Biotechniques 16:460-3
Goncharova, E I; Rossman, T G (1994) A role for metallothionein and zinc in spontaneous mutagenesis. Cancer Res 54:5318-23
Wang, Z; Rossman, T G (1993) Stable and inducible arsenite resistance in Chinese hamster cells. Toxicol Appl Pharmacol 118:80-6
Lee, Y W; Pons, C; Tummolo, D M et al. (1993) Mutagenicity of soluble and insoluble nickel compounds at the gpt locus in G12 Chinese hamster cells. Environ Mol Mutagen 21:365-71
Roy, N K; Rossman, T G (1992) Mutagenesis and comutagenesis by lead compounds. Mutat Res 298:97-103
Rossman, T G; Wolosin, D (1992) Differential susceptibility to carcinogen-induced amplification of SV40 and dhfr sequences in SV40-transformed human keratinocytes. Mol Carcinog 6:203-13
Rossman, T G; Roy, N K; Lin, W C (1992) Is cadmium genotoxic? IARC Sci Publ :367-75
Li, J H; Rossman, T G (1991) Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol Met 4:197-200

Showing the most recent 10 out of 15 publications